1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for individuals in Shannon City who are battling with opioid abuse and addiction is opioid maintenance therapy. Licensed centers and doctors are authorized to administer certain medications to opioid dependent clients, many of which are opioid-based also and are habit forming. With low enough amounts however, the individual doesn't experience being high but also does not experience severe cravings and isn't in opioid withdrawal. Methadone is the first medication administered for this sole purpose, but there are a few more choices currently to choose from.
Methadone is an opioid and is meant to be taken at an outpatient clinic licensed to administer the drug, that is taken daily as a pill or liquid. The price of the med is about $150 per month. Buprenorphine is also an opioid based drug, and is in pill form often taken every other day. But different from Methadone that is only be given in highly well-regulated clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is around three hundred dollars a month for the generic of the med. There is also a version of buprenorphine that contains the ingredient naloxone, that is a drug which blocks the effects of opiates. An individual taking this version of the drug, AKA Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken daily, and is priced approximately $450 monthly. Naltrexone is an additional drug used in opioid maintenance therapy, but unlike the other medications mentioned it's an opiate blocker and isn't an opioid. A person has the choice to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents an individual from experience being high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 monthly.
For All Drug and Alcohol Rehab Programs In Shannon City, Click Here.
